Kai-Uwe Jarr

Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis

Alyssa M. Flores, Niloufar Hosseini-Nassab, Kai-Uwe Jarr et al. · Nature Nanotechnology · 2020 · 267 citations · Full text

Nanoparticles, Inflammation, Pro-efferocytic Nanoparticles +11

Clonally expanding smooth muscle cells promote atherosclerosis by escaping efferocytosis and activating the complement cascade

Ying Wang, Vivek Nanda, Daniel DiRenzo et al. · Proceedings of the National Academy of Sciences · 2020 · 125 citations · Full text

Vascular Disease, Immunology, Immune Regulation +22

MicroRNA-20a inhibits stress-induced cardiomyocyte apoptosis involving its novel target Egln3/PHD3

Derk Frank, Johanne Gantenberg, Inka Boomgaarden et al. · Journal of Molecular and Cellular Cardiology · 2011 · 73 citations

Cell Regulation, Apoptosis, Immunology +8

The pleiotropic benefits of statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis

Kai-Uwe Jarr, Jianqin Ye, Yoko Kojima et al. · Nature Cardiovascular Research · 2022 · 51 citations · Full text

Inflammation, Thrombosis, Metabolic Syndrome +13

Chitinase 3 like 1 is a regulator of smooth muscle cell physiology and atherosclerotic lesion stability

Pavlos Tsantilas, Shen Lao, Zhiyuan Wu et al. · Cardiovascular Research · 2021 · 37 citations · Full text